Cargando…
Safety assessment of adjuvanted vaccines: Methodological considerations
Adjuvants mainly interact with the innate immune response and are used to enhance the quantity and quality of the downstream adaptive immune response to vaccine antigens. Establishing the safety of a new adjuvant-antigen combination is achieved through rigorous evaluation that begins in the laborato...
Autores principales: | Da Silva, Fernanda Tavares, Di Pasquale, Alberta, Yarzabal, Juan P, Garçon, Nathalie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514270/ https://www.ncbi.nlm.nih.gov/pubmed/26029975 http://dx.doi.org/10.1080/21645515.2015.1043501 |
Ejemplares similares
-
Vaccine Adjuvants: from 1920 to 2015 and Beyond
por: Di Pasquale, Alberta, et al.
Publicado: (2015) -
From discovery to licensure, the Adjuvant System story
por: Garçon, Nathalie, et al.
Publicado: (2016) -
Post-Marketing Safety Surveillance for the Adjuvanted Recombinant Zoster Vaccine: Methodology
por: Tavares-Da-Silva, Fernanda, et al.
Publicado: (2020) -
Safety Profile of the Adjuvanted Recombinant Zoster Vaccine in Immunocompromised Populations: An Overview of Six Trials
por: López-Fauqued, Marta, et al.
Publicado: (2021) -
37. Safety Profile of the Adjuvanted Recombinant Zoster Vaccine (RZV) in Immunocompromised Populations: an Overview of 6 Trials
por: Fauqued, Marta Lopez, et al.
Publicado: (2020)